Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de WuXi Biologics (Cayman) Inc?

Accepted Answer

Según el último estado financiero (Form-10K), WuXi Biologics (Cayman) Inc tiene un total de activos de $56,977, una ganancia neta profit de $3,356

Question 2

¿Cuáles son los ratios financieros clave para WXXWY?

Accepted Answer

El ratio corriente de WuXi Biologics (Cayman) Inc es 3.75, el margen neto es 17.97, las ventas por acción son $4.41.

Question 3

¿Cómo se desglosan los ingresos de WuXi Biologics (Cayman) Inc por segmento o geografía?

Accepted Answer

WuXi Biologics (Cayman) Inc largest revenue segment is Biologics, at a revenue of 15,972,158,570 in the most earnings release.For geography, North America is the primary market for WuXi Biologics (Cayman) Inc, at a revenue of 11,596,649,464.

Question 4

¿Es rentable WuXi Biologics (Cayman) Inc?

Accepted Answer

yes, según los últimos estados financieros, WuXi Biologics (Cayman) Inc tiene una ganancia neta profit de $3,356

Question 5

¿Tiene WuXi Biologics (Cayman) Inc alguna deuda?

Accepted Answer

yes, WuXi Biologics (Cayman) Inc tiene una deuda de 15,158

Question 6

¿Cuántas acciones en circulación tiene WuXi Biologics (Cayman) Inc?

Accepted Answer

WuXi Biologics (Cayman) Inc tiene un total de acciones en circulación de 4,105.93

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	20,054	18,675	17,034	15,268	10,290	5,612
Revenue Growth (YoY)	17%	10%	12%	48%	83%	41%
Cost of Revenue	11,500	11,024	10,206	8,544	5,461	3,079
Gross Profit	8,553	7,650	6,827	6,724	4,828	2,532
Selling, General & Admin	2,297	2,298	2,109	1,691	1,157	726
Research & Development	765	766	785	682	501	303
Operating Expenses	2,983	2,821	2,680	2,166	1,520	888
Other Non Operating Income (Expenses)	-5	-10	-10	-10	-9	--
Pretax Income	6,154	4,834	4,173	5,357	3,993	1,965
Income Tax Expense	1,232	889	603	807	484	273
Net Income	4,196	3,356	3,399	4,420	3,388	1,688
Net Income Growth	59%	-1%	-23%	30%	101%	67%
Shares Outstanding (Diluted)	4,185.75	4,227.16	4,348.87	4,375.9	4,421.79	4,209.16
Shares Change (YoY)	-2%	-3%	-1%	-1%	5%	5%
EPS (Diluted)	0.98	0.78	0.78	1.01	0.76	0.4
EPS Growth	62%	0%	-23%	32%	91%	57.99%
Free Cash Flow	1,759	1,287	447	-326	-3,091	-4,143
Free Cash Flow Per Share	0.42	0.3	0.1	-0.07	-0.69	-0.98
Gross Margin	42.64%	40.96%	40.07%	44.03%	46.91%	45.11%
Operating Margin	27.77%	25.85%	24.34%	29.84%	32.14%	29.29%
Profit Margin	20.92%	17.97%	19.95%	28.94%	32.92%	30.07%
Free Cash Flow Margin	8.77%	6.89%	2.62%	-2.13%	-30.03%	-73.82%
EBITDA	--	6,266	5,316	5,357	3,789	1,947
EBITDA Margin	--	33.55%	31.2%	35.08%	36.82%	34.69%
D&A For EBITDA	--	1,437	1,169	800	481	303
EBIT	5,570	4,829	4,147	4,557	3,308	1,644
EBIT Margin	27.77%	25.85%	24.34%	29.84%	32.14%	29.29%
Effective Tax Rate	20.01%	18.39%	14.45%	15.06%	12.12%	13.89%

WuXi Biologics (Cayman) Inc (WXXWY) Price

WXXWY Stock Price Chart

WXXWY Income

Follow-Up Questions